EcoDrugPlus

Ensembl ID : ENSCHYG00000001240
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSCHYG00000010362
Gene Symbol: -
Cross references: -
87 Possible Orthologues:

Ensembl ID : ENSCHYG00000000886
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSCHYG00000000757
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSCHYG00000000719
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSCHYG00000000569
Gene Symbol: -
Cross references: -
249 Possible Orthologues:

Ensembl ID : ENSCHYG00000000301
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSCHYG00000010422
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSCHYG00000010506
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSCHYG00000012452
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSCHYG00000000289
Gene Symbol: -
Cross references: -
379 Possible Orthologues:

Ensembl ID : ENSCHYG00000000074
Gene Symbol: -
Cross references: -
289 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).